Xu, Y., Xie, D., Cao, C., Wang, Z., Ju, Y., Guan, L., . . . Yin, X. (2025). PSMA-targeted CAR-macrophages drive glycolytic reprogramming for enhanced prostate cancer immunotherapy. Journal of Hematology & Oncology, 18(1), 1. https://doi.org/10.1186/s13045-025-01743-w
Chicago Style (17th ed.) CitationXu, Yangli, et al. "PSMA-targeted CAR-macrophages Drive Glycolytic Reprogramming for Enhanced Prostate Cancer Immunotherapy." Journal of Hematology & Oncology 18, no. 1 (2025): 1. https://doi.org/10.1186/s13045-025-01743-w.
MLA (9th ed.) CitationXu, Yangli, et al. "PSMA-targeted CAR-macrophages Drive Glycolytic Reprogramming for Enhanced Prostate Cancer Immunotherapy." Journal of Hematology & Oncology, vol. 18, no. 1, 2025, p. 1, https://doi.org/10.1186/s13045-025-01743-w.